DIANA LESZCZEWICZ: Open Payments
NPI 1770129272 · ELKTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 39 payments from 15 companies in 2025. Trend: 2023 $335 · 2024 $442 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| Corium, LLC | 4 | $76 |
| Novo Nordisk Inc | 4 | $73 |
| PFIZER INC. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Biogen, Inc. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, Azstarys, NURTEC ODT, REXULTI, Ozempic, HETLIOZ, Jornay PM.
Industry payments across KY — which companies pay providers there.
